The Concept of Type-1 and Type-2 Helper T Cells and Their Cytokines in Humans

References

• Mosmann T. R., Cherwinski H., Bond M. W., Giedlin M. A., Coffman R L. Two types of murine T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 1986; 136: 2348–2357
   PubMed Web of Science ®Google Scholar
• Mosmann T. R., Coffman R. L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann. Rev. Immunol. 1989; 7: 145–173
   PubMed Web of Science ®Google Scholar
• Romagnani S., Maggi E. Th1 versus Th2 responses in AIDS. Curr. Opin. Immunol. 1994; 6: 616–622
   PubMed Web of Science ®Google Scholar
• Romagnani S. Biology of human Th1 and Th2 cells. J. din. Immunol. 1995; 15: 121–129
   Web of Science ®Google Scholar
• Maggi E., Del Prete G., Macchia D., Parronchi P., Tiri A., Chretien I., Ricci M., Romagnani S. Profiles of lymphokine activites and helper function for IgE in human T cell clones. Eur. J. Immunol. 1988; 18: 1045–1050
   PubMed Web of Science ®Google Scholar
• Paliard X., de Waal Malefijt R., Yssel H., Blanchard D., Chretien I., Abrams J., de Vries E. J., Spits H. Simultaneous production of IL-2, IL-4, and IFN-γ by activated human CD4+ and CD8+ T cell clones. J. Immunol. 1988; 141: 849–855
   PubMed Web of Science ®Google Scholar
• Openshaw P., Murphy E. E., Hosken N. A., Maino V., Davis K., Murphy K., O'Garra A. Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations. J. Exp. Med. 1995; 182: 1357–1367
   PubMed Web of Science ®Google Scholar
• Del Prete G., De Carli M., Mastromauro C., Macchia D., Biagiotti R., Ricci M., Romagnani S. Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J. Clin. Invest. 1991; 88: 346–351
   PubMed Web of Science ®Google Scholar
• Haanen J. B. A.G., de Waal Malefijt R., Res P. C. M., Kraakman E. M., Ottenhoff T. H. M., de Vries R. R. P., Spits H. Selection of a human T helper type 1-like T cell subset by Mycobacteria. J. Exp. Med. 1991; 174: 583–592
   PubMed Web of Science ®Google Scholar
• Salgame P., Abrams J. S., Clayberger C., Goldstein H., Convitt J., Modlin R. L., Bloom B. R. Differing lymphokine profiles and functional subsets of human CD4+ and CD8+ T cell clones. Science 1991; 254: 279–281
   PubMed Web of Science ®Google Scholar
• Wierenga E. A., Snoek M., de Groot C., Chretien I., Bos J. D., Jansen H. M., Kapsenberg M. L. Evidence for compartmentalization of functional subsets of CD4+ T lymphocytes in atopic patients. J. Immunol. 1990; 144: 4651–4656
   PubMed Web of Science ®Google Scholar
• Parronchi P., Macchia D., Piccinni M-P., Biswas P., Simonelli C., Maggi E., Ricci M., Ansari A. A., Romagnani S. Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. Proc. Natl. Acad. Sci. USA 1991; 88: 4538–4542
   PubMed Web of Science ®Google Scholar
• Del Prete G., De Carli M., Almerigogna F., Giudizi M-G., Biagiotti R., Romagnani S. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J. Immunol. 1993; 150: 353–360
   PubMed Web of Science ®Google Scholar
• Del Prete G., De Carli M., Ricci M., Romagnani S. Helper activity for immunoglobulin synthesis by Th1 and Th2 human T-cell clones: the help of Th1 clones is limited by their cytolytic capacity. J. Exp. Med. 1991; 174: 809–813
   PubMed Web of Science ®Google Scholar
• Del Prete G., De Carli M., Lammel R. M., D'Elios M. M., Daniel K. C., Giusti B., Abbate R., Romagnani S. Th1 and Th2 T-helper cells exert opposite regulatory effects on procoagulant activity and tissue factor production by human monocytes. Blood 1995; 86: 250–257
   PubMed Web of Science ®Google Scholar
• Fong T. A., Mosmann T. R. Alloreactive murine CD8+ T cell clones secrete the Th1 pattern of cytokines. J. Immunol. 1990; 144: 1744–1752
   PubMed Web of Science ®Google Scholar
• Erard F., Wild M-T., Garcia-Sanz J. A., Le Gros G. Switch of CD8 T cells to noncytolytic CD8− CD4− cells that make Th2 cytokines and help B cells. Science 1993; 260: 1802–1805
   PubMed Web of Science ®Google Scholar
• Sad S., Marcotte R., Mosmann T. R. Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines. Immunity 1995; 2: 271–279
   PubMed Web of Science ®Google Scholar
• Croft M., Carter L., Swain S. L., Dutton R. W. Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles. J. Exp. Med. 1994; 180: 1715–1728
   PubMed Web of Science ®Google Scholar
• Maggi E., Giudizi M-G., Biagiotti R., Annunziato F., Manetti R., Piccinni M-P., Parronchi P., Sampognaro S., Giannarini L., Zuccati G., Romagnani S. Th2-like CD8+ cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection. J. Exp. Med. 1994; 180: 489–495
   PubMed Web of Science ®Google Scholar
• Birkhofer A., Rehbock J., Fricke H. T lymphocytes from the normal human peritoneum contain high frequencies of Th2-type CD8+ T cells. Eur. J. Immunol. 1996; 26: 957–960
   PubMed Web of Science ®Google Scholar
• Sad S., Mosmann T. R. Interleukin (IL)-4, in the absence of antigen stimulation induces an anergy-like state in differentiated CD8+ Tel cells: loss of IL-2 synthesis and autonomous proliferation but retention of cytotoxicity and synthesis of other cytokines. J. Exp. Med. 1995; 182: 1505–1515
   PubMed Web of Science ®Google Scholar
• Seder R. A., Le Gros G. The functional role of CD8+ T helper type 2 cells. J. Exp. Med. 1995; 181: 5–7
   PubMed Web of Science ®Google Scholar
• Scheel D., Richter E., Toellner K-M., Reiling N., Key G., Wacker H-H., Ulmer A. J., Flad H. D., Gerdes J. Correlation of CD26 expression with Th1-like reactions in granulomatous diseases. Leukocyte Typing V. White cell differentiation antigens, S. F. Schlossmann, et al. Oxford University Press, Oxford 1995; 1111–1114
   Google Scholar
• Kanegane H., Kasahara Y., Niida Y., Yachie A., Sugii S., Takatsu K., Taniguchi N., Miyawaki T. Expression of L-selectin (CD62L) discriminates Th1- and Th2-like cytokine-producing memory CD4+ T cells. Immunology 1996; 87: 186–190
   PubMed Web of Science ®Google Scholar
• Assenmacher M., Scheffold A., Schmitz J., Segura Checa J. A., Miltenyi S., Radbruch A. Specific expression of surface interferon-7 on interferon-γ-producing T cells from mouse and man. Eur. J. Immunol. 1996; 26: 263–267
   PubMed Web of Science ®Google Scholar
• Del Prete G., De Carli M., Almerigogna F., Daniel K. C., D'Elios M. M., Zancuoghi G., Vinante E., Pizzolo G., Romagnani S. Preferential expression of CD30 by human CD4+ T cells producing Th2-type cytokines. FASEB J. 1995; 9: 81–86
   PubMed Web of Science ®Google Scholar
• Hamann D., Hilkens C. M. U., Grogan J. L., Lens S. M. A., Kapsenberg M. L., Yazdanbakhsh M., van Lier R. A. W. CD30 expression does not discriminate between human Th1- and Th2-type T cells. J. Immunol. 1996; 156: 1387–1391
   PubMed Web of Science ®Google Scholar
• Seitzer U., Flad H-D., Gerdes J. Within the spectral forms of leprosy cell bound CD30 cannot be regarded as an operational marker for a Th2-like reaction. J. Leukoc. Biol. 1996; 59: 311–315
   PubMed Web of Science ®Google Scholar
• Del Prete G., De Carli M., D'Elios M. M., Daniel K. C., Almerigogna F., Alderson M., Smith C. A., Thomas E., Romagnani S. CD30-mediated signalling promotes the development of human Th2-like T cells. J. Exp. Med. 1995; 182: 1655–1661
   PubMed Web of Science ®Google Scholar
• Chilosi M., Facchetti F., Notarangelo L. D., Romagnani S., Del Prete G., Almerigogna F., De Carli M., Pizzolo G. CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn's syndrome. Evidence for a Th2-mediated condition. Eur. J. Immunol. 1996; 26: 329–334
   PubMed Web of Science ®Google Scholar
• Schandené L., Ferster A., Mascart-Lemone F., Crusiaux A., Gerard C., Marchant A., Lybin M., Velu T., Sariban E., Goldman M. T helper type 2-like cells and therapeutic effects of interferon-7 in combined immuno-deficiency with hypereosinophilia (Ommen's syndrome). Eur. J. Immunol. 1993; 23: 56–60
   PubMed Web of Science ®Google Scholar
• Manetti R., Annunziato F., Biagiotti R., Giudizi M-G., Piccinni M-P., Giannarini L., Sampognaro S., Parronchi P., Vinante F., Pizzolo G., Romagnani S. CD30 expression by CD8+ T cells producing type 2 helper cytokines. Evidence for large numbers of CD8+CD30+ T cell clones in human immunodeficiency virus infection. J. Exp. Med. 1994; 180: 2407–2412
   PubMed Web of Science ®Google Scholar
• Triebel F., Jitsukawa S., Baixeras E., Roman-Roman S., Genevee C., Viegas-Pequignot E., Hercend T. LAG-3, a novel lymphocyte activation gene closely related to CD4. J. Exp. Med. 1990; 171: 1393–1405
   PubMed Web of Science ®Google Scholar
• Annunziato F., Manetti R., Tomasevic L., Giudizi M-G., Biagiotti R., Giannò V., Germane P., Mavilia C., Maggi E., Romagnani S. Expression and release of LAG-3-associated protein by human CD4+ T cells are associated with IFN-γ. FASEB J. 1996; 10: 767–776
   Web of Science ®Google Scholar
• Swain S. L., Weinberg A. D., English M. CD4+ T-cell subsets: lymphokine secretion of memory cells and effector cells which develop from precursors in vitro. J. Immunol. 1990; 144: 1788–1799
   PubMed Web of Science ®Google Scholar
• Kamogawa Y., Minasi L. E., Carding S. R., Bottomly K., Flavell R. A. The relationship of IL-4- and IFN-γ-producing T cells studied by lineage ablation of IL-4-producing cells. Cell 1993; 75: 985–995
   PubMed Web of Science ®Google Scholar
• Seder R. A., Paul W. E. Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu. Rev. Immunol. 1994; 12: 635–674
   PubMed Web of Science ®Google Scholar
• O'Garra A., Murphy K. Role of cytokines in development of Th1 and Th2 cells. Chem. Immunol. 1996; 63: 1–13
   PubMedGoogle Scholar
• Hsieh C-S., Macatonia S. E., O'Garra A., Murphy K. T cell genetic background determines default T helper phenotype development in vitro. J. Exp. Med. 1995; 181: 713–721
   PubMed Web of Science ®Google Scholar
• Hosken N. A., Shibuya K., Heath A. W., Murphy K., O'Garra A. The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-αβ-transgenic model. J. Exp. Med. 1995; 182: 1579–1584
   PubMed Web of Science ®Google Scholar
• Kuchroo Y. K., Prabhu Das M., Brown J. A., Ranger A. M., Zamvil S. S., Sobel R. A., Weiner H. L., Nabavi N., Glimcher L. H. B7–1 and B7–2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 1995; 80: 707–718
   PubMed Web of Science ®Google Scholar
• Stuber E., Strober W., Neurath M. Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J. Exp. Med. 1996; 183: 693–698
   PubMed Web of Science ®Google Scholar
• Hsieh C-S., Macatonia S. E., Tripp C. S., Wolf S. F., O'Garra A., Murphy K. M. Development of TH1 CD4+ T cells through IL-12 produced by Leisteria-induced macrophages. Science 1993; 260: 547–549
   PubMed Web of Science ®Google Scholar
• Seder R. A., Gazzinelli R., Sher A., Paul W. E. Interleukin 12 acts directly on CD4+ cells to enhance priming for interferon γ production and diminishes interleukin 4 inhibition of such priming. Proc. Natl. Acad. Sci. USA 1993; 90: 10188–10192
   PubMed Web of Science ®Google Scholar
• Wenner C., Guler M. L., Macatonia S. E., O'Garra A., Murphy K. M. Roles of IFN-γ and IFN-α in IL-12-induced Th1 development. J. Immunol. 1996; 156: 1442–1447
   PubMed Web of Science ®Google Scholar
• Seder R. A., Paul W. E., Davis M. M., Fazekas de St Groth B. The presence of interleukin 4 during in vitro priming determines the lymphocyte-producing potential of CD4+ T cells from T cell receptor transgenic mice. J. Exp. Med. 1992; 176: 1091–1098
   PubMed Web of Science ®Google Scholar
• Aoki I., Kinzer C., Shirai A., Paul W. E., Klinman D. M. IgE receptorpositive non-B/non-T cells dominate the production of interleukin 4 and interleukin 6 in immunized mice. Proc. Natl. Acad. Sci. USA 1995; 92: 2534–2538
   PubMed Web of Science ®Google Scholar
• Schmitz J., Thiel A., Kuhn R., Rajewski K., Muller W., Assenmacher M., Radbruch A. Induction of interleukin-4 (IL-4) expression in T helper (Th) cells is not dependent on IL-4 from non-T cells. J. Exp. Med. 1994; 179: 1349–1353
   PubMed Web of Science ®Google Scholar
• Bendelac A. Mouse NK1+ T cells. Curr. Opin. Immunol. 1995; 7: 367–374
   PubMed Web of Science ®Google Scholar
• Yoshimoto T., Bendelac A., Watson C., Hu-Li J., Paul W. E. Role of NK1.1+ T cells in a Th2 response and in immunoglobulin E production. Science 1995; 270: 1845–1847
   PubMed Web of Science ®Google Scholar
• Croft M., Swain S. L. Recently activated naive CD4 T cells can help resting B cells, and produce sufficient autocrine IL-4 to drive differentiation to secretion of T helper 2-type cytokines. J. Immunol. 1995; 154: 4269–4282
   PubMed Web of Science ®Google Scholar
• Romagnani S. Lymphokine production by human T cells in disease states. Ann. Rev. Immunol. 1994; 12: 227–257
   PubMed Web of Science ®Google Scholar
• Manetti R., Gerosa F., Giudizi M-G., Biagiotti R., Parronchi P., Piccinni M-P., Sampognaro S., Maggi E., Romagnani S., Trinchieri G. Interleukin 12 induces stable priming for interferon γ (IFN-γ) production during differentiation of human T helper (Th) cells and transient IFN-γ production in established Th2 cell clones. J. Exp. Med. 1994; 179: 1273–1283
   PubMed Web of Science ®Google Scholar
• Maggi E., Parronchi P., Manetti R., Simonelli C., Piccinni M-P., Santoni Rugiu F., De Carli M., Ricci M., Romagnani S. Reciprocal regulatory role of IFN-γ and IL-4 on the in vitro development of human Th1 and Th2 clones. J. Immunol. 1992; 148: 2142–2147
   PubMed Web of Science ®Google Scholar
• Demeure C. E., Yang L-P., Byun D. G., Ishihara H., Vezzio N., Delespesse G. Human naive CD4 T cells produce interleukin-4 at priming and acquire a Th2 phenotype upon repetitive stimulations in neutral conditions. Eur. J. Immunol. 1995; 25: 2722–2725
   PubMed Web of Science ®Google Scholar
• Kalinski P., Hilkens C. M. U., Wierenga E. A., van der Pouw-Kraan T. C. T.M., van Lier R. A. W., Bos J. D., Kapsenberg M. L., Snijdewint F. G. M. Functional maturation of human naive T helper cells in the absence of accessory cells. J. Immunol. 1995; 154: 3753–3760
   PubMed Web of Science ®Google Scholar
• Reiner S. L., Locksley R. M. The regulation of immunity to Leishmania Major. Annu. Rev. Immunol. 1995; 13: 151–177
   PubMed Web of Science ®Google Scholar
• Carvalho E. M., Bacellar O., Brownell C., Regis T., Coffman R. L., Reed S. G. Restoration of IFN-γ production and lymphocyte proliferation in visceral leishmaniasis. J. Immunol. 1994; 152: 5949–5956
   PubMed Web of Science ®Google Scholar
• Kemp M., Theander T. G., Kharazmi A. The contrasting roles of CD4+ T cells in intracellular infections in humans: leishmaniasis as an example. Immunol. Today 1996; 17: 13–16
   PubMedGoogle Scholar
• Pirmez C., Yamamura M., Uyemura K., Paes-Oliveira M., Conceicao-Silva F., Modlin R. L. Cytokine patterns in the pathogenesis of human leishmaniasis. J. Clin. Invest. 1993; 91: 1390–1395
   PubMed Web of Science ®Google Scholar
• Badarò R., Johnson W. D. The role of interferon-γ in the treatment of visceral and diffuse cutaneous leishmaniasis. J. Infect. Dis. 1993; 167(suppl. 1)S13–17
   PubMedGoogle Scholar
• Finkelman F. D., Pearce E. J., Urban J. F., Jr, Sher A. Regulation and biological function of helminth-induced cytokine responses. Immunoparasitol. Today 1991; 12: A62–66
   Google Scholar
• Capron M., Capron A. Immunoglobulin E and effector cells in Schistosomiasis. Science 1994; 264: 1876–1877
   PubMed Web of Science ®Google Scholar
• Sher A., Gazzinelli R. T., Oswald I. P., Clerici M., Kullberg M., Pearce E. J., Berzofsky J. A., Mosmann T. R., James S. L., Morse H. C. Role of T cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection. Immunol. Rev. 1992; 127: 183–204
   PubMed Web of Science ®Google Scholar
• Urban J. F., Maliszewski C. R., Madden K. B., Katona I. M., Finkelman F D. IL-4 treatment can cure established gastrointestinal nematode infections in immunocompetent and immunodeficient mice. J. Immunol. 1995; 154: 4675–4684
   Google Scholar
• Pierce E. J., Caspar P., Grzych J-M., Lewis F. A., Sher A. Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni. J. Exp. Med. 1991; 173: 159–166
   PubMed Web of Science ®Google Scholar
• Wynn T. A., Eltoum I., Cheever A. W., Lewis F. A., Gause W. C., Sher A. Analysis of cytokine mRNA expression during primary granuloma formation induced by eggs of Schistosoma mansoni. J. Immunol. 1993; 151: 1430–1440
   PubMed Web of Science ®Google Scholar
• Cheever A. W., Finkelman F. D., Caspar P., Heiny S., Macedonia J. G., Sher A. Treatment with anti-IL-2 antibodies reduces hepatic pathology and eosinophilia in Schistosoma mansoni-infected mice while selectively inhibiting T cell IL-5 production. J. Immunol. 1992; 148: 3244–3248
   PubMed Web of Science ®Google Scholar
• Wynn T. A., Eltoum I., Oswald I. P., Cheever A. W., Sher A. Endogenous interleukin 12 (IL-12) regulates granuloma formation induced by eggs of Schistosoma mansoni and exogenous IL-12 both inhibits and prophylactically immunizes against egg pathology. J. Exp. Med. 1994; 179: 1551–1561
   PubMed Web of Science ®Google Scholar
• Roberts M., Butterworth A. E., Kimani G., Kamau T., Fulford A. J., Dunne D. W., Ouma J. H., Sturrock R. F. Immunity after treatment of human schistosomiasis: association between cellular responses and resistance to reinfection. Infect. Immun. 1993; 61: 4984–4993
   PubMed Web of Science ®Google Scholar
• Cuissinier-Paris P., Dessein A. J. Schistosoma-specific helper T cell clones from subjects resistant to infection by Schistosoma mansoni are Th0/2. Eur. J. Immunol. 1995; 25: 2295–2302
   PubMed Web of Science ®Google Scholar
• Daugelat S., Kauffman S. H. E. Role of Th1 and Th2 cells in bacterial infections. Chem. Immunol. 1995; 63: 66–97
   Google Scholar
• Yssel H., Shanafelt M. C., Soderberg C., Schneider P. V., Anzola J., Peltz G. Borrelia burgdorferi activates a T helper type 1-like T cell subset in Lyme arthritis. J. Exp. Med. 1991; 174: 593–601
   PubMed Web of Science ®Google Scholar
• Lahesmaa R., Yssel H., Batsford S., Luukkainen R., Mootonen T., Steinman L., Peltz G. Yersinia enterocolitica activates a T helper type 1-like T cell subset in reactive arthritis. J. Immunol. 1992; 148: 3079–3085
   PubMed Web of Science ®Google Scholar
• Kreiss C., Blum A. L., Malfertheiner P. Peptic ulcer pathogenesis. Curr. Opin. Immunol. 1995; 11: 25–31
   Google Scholar
• Marchetti M., Aricò B., Burroni D., Figura N., Rappuoli R., Ghiara P. Development of a mouse model of Helicobacter pylori infection that mimics human Disease. Science 1995; 267: 1655–1668
   PubMed Web of Science ®Google Scholar
• Mohammadi M., Czinn S., Nedrud J. Helicobacter-specific cell-mediated immune responses display a predominant Th1 phenotype and promote a delayed-type hypersensitivity response in the stomachs of mice. J. Immunol. 1996; 156: 4729–4736
   PubMed Web of Science ®Google Scholar
• D'Elios M. M., Manghetti M., De Carli M., Costa F., Baldari C. T., Burroni D., Telford J. L., Romagnani S., Del Prete G. Th1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J. Immunol. 1997; 158: 962–967
   PubMed Web of Science ®Google Scholar
• Kirsner J. B., Shorter R. G. Recent developments in “nonspecific” inflammatory bowel disease. N. Engl. J. Med. 1982; 306: 775–837
   PubMed Web of Science ®Google Scholar
• Niessner M., Volk B. A. Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative transcribed polymerase chain reaction (RT-PCR). Clin. exp. Immunol. 1995; 101: 428–435
   PubMed Web of Science ®Google Scholar
• De Carli M., D'Elios M. M., Zancuoghi G., Romagnani S., Del Prete G. Human Th1 and Th2 cells: functional properties, regulation of development and role in autoimmunity. Autoimmunity 1994; 18: 301–308
   PubMedGoogle Scholar
• Windhagen A., Nicholson L. B., Weiner H. L., Kuchroo V. K., Hafler D. A. Role of Th1 and Th2 cells in neurologic disorders. Chem. Immunol. 1996; 63: 171–186
   PubMedGoogle Scholar
• Zamvil S. S., Steinman L. The T lymphocyte in experimental allergic encephalomyelitis. Annu. Rev. Immunol. 1990; 8: 579–621
   PubMed Web of Science ®Google Scholar
• Voskuhl R. R., Martin R., Bergman C., Dalai M., Ruddle N. H., McFarland H. F. T helper 1 (Th1) functional phenotype of human myelic basic protein-specific T lymphocytes. Autoimmunity 1993; 15: 137–143
   PubMed Web of Science ®Google Scholar
• Chen Y., Kuchroo Y. V., Inobe J-I., Hafler D. A., Weiner H. L. Regulatory T-cell clones induced by oral tolerance and suppression of autoimmune encephalomyelitis. Science 1994; 265: 1237–1240
   PubMed Web of Science ®Google Scholar
• Renno T., Zeine R., Girard J. M., Gillani S., Dodelet V., Owens T. Selective enrichment of Th1 CD45RBlow CD4+ T cells in autoimmune infiltrates in experimental allergic encephalomyelitis. Int. Immunol. 1994; 6: 347–354
   PubMed Web of Science ®Google Scholar
• Khoury S. J., Hancock W. W., Weiner H. L. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential up regulation of transforming growth factor β, interleukin 4 and prostaglandin E expression in the brain. J. Exp. Med. 1992; 176: 1335–1364
   PubMed Web of Science ®Google Scholar
• Cua D. J., Hinton D. R., Stohlman S. A. Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice. J. Immunol. 1995; 155: 4052–4059
   PubMed Web of Science ®Google Scholar
• Ferber I. A., Brocke S., Taylor-Edwards C., Ridgway W., Dinisco C., Steinman L., Dalton D., Garrison Fayhman C. Mice with a disrupted IFN-gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 1996; 156: 5–7
   PubMed Web of Science ®Google Scholar
• Sharief M. K., Hentges R. Association between tumor necrosis factor alpha and disease progression in patients with multiple sclerosis. N. Engl. J. Med. 1991; 325: 467–472
   PubMed Web of Science ®Google Scholar
• Brod S. A., Benjamin D., Hafler D. A. Restricted T cell expression of IL2, IFN-γ mRNA in human inflammatory disease. J. Immunol. 1991; 147: 810–815
   PubMed Web of Science ®Google Scholar
• Olsson T. Cytokines in neuro-inflammatory disease: role of myelin-auto reactive T cell production of interferon-gamma. J. Neuroimmunol. 1993; 40: 211–218
   Web of Science ®Google Scholar
• Del Prete G., Tiri A., Mariotti S., Pinchera A., Ricci M., Romagnani S. Enhanced production of gamma-interferon by thyroid-derived T cell clones from patients with Hashimoto's thyroiditis. Clin. exp. Immunol. 1987; 69: 323–331
   PubMed Web of Science ®Google Scholar
• Margolick J. B., Weetman A. P., Burman K. D. Immunohistochemical analysis of intrathyroidal lymphocytes in Graves' disease: evidence of activated T cells and production of interferon-gamma. Clin. Immunol. Immunopathol. 1988; 47: 208–218
   PubMedGoogle Scholar
• Zheng R. Q. H., Abney E. R., Chu C. Q., Field M., Maini R. N., Lamb J. R., Feldmann M. Detection of in vivo production of tumor necrosis factor-alpha by human thyroid epithelial cells. Immunology 1992; 75: 456–462
   PubMed Web of Science ®Google Scholar
• De Carli M., D'Elios M. M., Mariotti S., Marcocci C., Pinchera A., Ricci M., Romagnani S., Del Prete G. Cytolytic T cells with Th1-like cytokine profile predominate in retroorbital lymphocytic infiltrates of Graves' ophtalmopathy. J. Clin. Endocrinol. Metab. 1993; 77: 1120–1124
   PubMed Web of Science ®Google Scholar
• Mullins R. J., Cohen S. B. A., Webb L. M. C., Chernajovsky Y., Dayan C. M., Londei M., Feldmann M. Identification of thyroid stimulating hormone receptor-specific T cells in Graves' disease thyroid using autoantigen-transfected Epstein Barr virus-transformed B cell lines. J. Clin. Invest. 1995; 96: 30–37
   PubMed Web of Science ®Google Scholar
• Goldman M., Druet P., Gleichmann E. Th2 cells in systemic autoimmunity: insights from allogenic diseases and chemically-induced autoimmunity. Immunol. Today 1991; 12: 223–227
   PubMedGoogle Scholar
• Prigent P., Saoudi A., Pannetier C., Graber P., Bonnefoy J-Y., Druet P., Hirsch F. Mercuric chloride, a chemical responsible for T helper cell (Th)2-mediated autoimmunity in Brown Norway rats, directly triggers T cells to produce interleukin-4. J. Clin. Invest. 1995; 96: 1484–1489
   PubMed Web of Science ®Google Scholar
• Dueymes M., Barrier J., Bescancenot J. F., Clèdes J., Conri C., Dien G., Drosos A. A., Dueymes J. M., Galanaud P., Grobois B., Guillevin L., Hatron P. Y., Isenberg D. A., Jorgensen C., Jouquant J., Lamour A., Le Goff P., Loungy-Boursier M., Maran R., Massot C., Meyer O., Mottier D., Moutsopoulos H. M., Philippe P., Piette J. C., Sany J., Series C., Shoenfeld Y., Youinou P. Relationship of IL-4 to isotypic distribution of anti-DS DNA antibodies in SLE. Int. Arch. Allergy Appl. Immunol. 1993; 101: 408–415
   Google Scholar
• Hagiwara E., Gourley M. F., Lee M., Klinman D. M. Altered ratio of Th1:Th2 type cytokine secreting cells in patients with systemic lupus erythematosus. J. Immunol. 1997, in press
   Google Scholar
• Caligaris-Cappio F., Bertero M. T., Converse M., Stacchini A., Vinante F., Romagnani S., Pizzolo G. Circulating levels of soluble CD30, a marker of cells producing Th2-type cytokines, are increased in patients with systemic lupus erythematosus and correlate with disease activity. Clin. Exp. Rheum. 1995; 13: 339–343
   PubMed Web of Science ®Google Scholar
• Kovacs E. J. Fibrogenic cytokines: the role of immune mediators in the development of scar tissue. Immunol. Today 1991; 12: 17–23
   PubMedGoogle Scholar
• Postletwhite A. E., Holness M. A., Katai H., Raghow R. Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4. J. Clin. Invest. 1992; 90: 1479–1485
   PubMed Web of Science ®Google Scholar
• Famularo G., Procopio A., Giacomelli R., Danese C., Sacchetti S., Perego M. A., Santoni A., Tonietti G. Soluble interleukin-2 receptor, interleukin-2 and interleukin-4 in sera and supernatants from patients with progressive systemic sclerosis. Clin. exp. Immunol. 1990; 81: 368–372
   PubMed Web of Science ®Google Scholar
• Kay A. B., Ying S., Varney V., Gaga M., Durham S. R., Moqbel R., Wardlaw A. J., Hamid Q. Messenger RNA expression of the cytokine gene cluster interleukin-3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase reactions in atopic subjects. J. Exp. Med. 1991; 173: 775–778
   PubMed Web of Science ®Google Scholar
• Maggi E., Biswas P., Del Prete G., Parronchi P., Macchia D., Simonelli C., Emmi L., De Carli M., Tiri A., Ricci M., Romagnani S. Accumulation of Th2-like helper T cells in the conjunctiva of patients with vernal conjunctivitis. J. Immunol. 1991; 146: 1169–1174
   PubMed Web of Science ®Google Scholar
• van der Heijden F. L., Wierenga E. A., Bos J. D., Kapsenberg M. L. High frequency of IL-4-producing CD4+ allergen-specific T lymphocytes in atopic dermatitis lesional skin. J. Invest. Dermatol. 1991; 97: 389–394
   PubMed Web of Science ®Google Scholar
• Robinson D. S., Hamid Q., Ying S., Tsicopoulos A., Barkans J., Bentley A. M., Corrigan C. J., Durham S. R., Kay A. B. Predominant Th2-like Bronchoalveolar T-lymphocyte Population in Atopic Asthma. New Engl. J. Med. 1992; 326: 295–304
   Web of Science ®Google Scholar
• Del Prete G., De Carli M., D'Elios M. M., Maestrelli P., Ricci M., Fabbri L., Romagnani S. Allergen exposure induces the activation of allergen-specific Th2 cells in the airway mucosa of patients with allergic respiratory disorders. Eur. J. Immunol. 1993; 23: 1445–1449
   PubMed Web of Science ®Google Scholar
• Robinson D., Hamid Q., Bentley A., Ying S., Kay A. B., Durham S. R. Activation of CD4+ T cells, increased Th2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J. Allergy Clin. Immunol. 1993; 92: 313–324
   PubMed Web of Science ®Google Scholar
• Varney V. A., Hamid Q., Gaga M., Ying S., Jacobson M., Frew A. J., Kay A. B., Durham S. R. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA. Expression during allergen-induced late-phase cutaneous responses. J. Clin. Invest. 1993; 92: 644–651
   PubMed Web of Science ®Google Scholar
• Secrist H., Chelen C. J., Wen Y., Marshall J. D., Umetsu D. T. Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals. J. Exp. Med. 1993; 178: 2123–2130
   PubMed Web of Science ®Google Scholar
• Jutel M., Pichler W. J., Skrbic D., Urwyler A., Dahinden C., Muller U. R. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-γ secretion in specific allergen-stimulated T cell cultures. J. Immunol. 1995; 154: 4187–4194
   PubMed Web of Science ®Google Scholar
• Del Prete G., Maggi E., Parronchi P., Chretien L., Tiri A., Macchia D., Ricci M., Banchereau J., De Vries J. E., Romagnani S. IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants. J. Immunol. 1988; 140: 4193–4198
   PubMed Web of Science ®Google Scholar
• Jabara H. H., Fu S. M., Geha R. S., Vercelli D. CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells. J. Exp. Med. 1990; 172: 1861–1864
   PubMed Web of Science ®Google Scholar
• Zurawski G., de Vries J. E. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol. Today 1994; 15: 19–26
   PubMedGoogle Scholar
• Parronchi P., De Carli M., Manetti R., Simonelli C., Piccinni M-P., Macchia D., Maggi E., Del Prete G., Ricci M., Romagnani S. Aberrant interleukin (IL)-4 and IL-5 production in vitro by CD4+ helper T cells from atopic subjects. Eur. J. Immunol. 1992; 22: 1615–1620
   PubMed Web of Science ®Google Scholar
• Romagnani S. Atopic allergy and other hypersensitivities. Curr. Opin. Immunol. 1995; 7: 745–750
   PubMed Web of Science ®Google Scholar